Lack of inverse agonistic activity of nebivolol, its d- and l-enantiomers and of in vivo metabolized nebivolol in human myocardium

Author： Bundkirchen A. Nguyen Q. Brixius K. Bolck B. Mehlhorn U. Schwinger R.H.G.

Publisher： Elsevier

ISSN： 0014-2999

Source： European Journal of Pharmacology, Vol.476, Iss.1, 2003-08, pp. : 97-105

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Modification of pharmacological activity of nebivolol due to Maillard reaction

By Patil Dipak D. Patil Chandragouda R.

Pharmaceutical Development and Technology, Vol. 18, Iss. 4, 2013-08 ,pp. : 844-851

Informa Healthcare

Access to resources Recommend Favorite

Nebivolol: a review

By Cockcroft John

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 4, 2004-04 ,pp. : 893-899

Informa Healthcare

Access to resources Recommend Favorite

Pharmacology of Nebivolol

By Mangrella M. Rossi F. Fici F. Rossi F.

Pharmacological Research, Vol. 38, Iss. 6, 1998-12 ,pp. : 419-431

Academic Press

Access to resources Recommend Favorite

Nebivolol: A Review of its Use in the Management of Hypertension and Chronic Heart Failure

By Moen Marit D. Wagstaff Antona J.

Drugs, Vol. 66, Iss. 10, 2006-01 ,pp. : 1389-1409

Adis International

Access to resources Recommend Favorite

Nebivolol: In the Treatment of Hypertension in the US

By Baldwin Claudine M. Keam Susan J.

American Journal of Cardiovascular Drugs, Vol. 9, Iss. 4, 2009-08 ,pp. : 253-260

Adis International

Access to resources Recommend Favorite